Literature DB >> 21193

Patterns of plasminogen activator production in cultured normal embryonic cells.

S T Rohrlich, D B Rifkin.   

Abstract

Cultured normal low-passage embryo fibroblasts, from a number of species, and two untransformed clones of a Balb/3T3 line elaborate increasing amounts of plasminogen activator (PA) as they approach confluence; the low-passage cells then lose this PA activity after reaching confluence, while the 3T3 cells retain it indefinitely. Even at their peaks, however, the PA activities of the low-passage cells remain well below those of the corresponding virally or spontaneously transformed cells. The PA increases in normal cells are probably a result of PA production rather than of adsorption of secreted PA to the cell surface, or of changes in cell-associated protease inhibitors. The elaboration of PA by normal cells is dependent upon their metabolic activity, such that the level of serum supplementation and the growth phase of the culture directly influence the level of cell-associated PA observed. In addition, there may be a component of serum which exerts a negative control on PA production and which is not an acid-labile protease inhibitor.

Mesh:

Substances:

Year:  1977        PMID: 21193      PMCID: PMC2111562          DOI: 10.1083/jcb.75.1.31

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  20 in total

1.  Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins.

Authors:  S Strickland; W H Beers
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

2.  Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator.

Authors:  J Unkeless; K Dano; G M Kellerman; E Reich
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

3.  Suppression of fibrinolysin T activity fails to restore density-dependent growth inhibition to SV3T3 cells.

Authors:  I N Chou; P H Black; R O Roblin
Journal:  Nature       Date:  1974-08-30       Impact factor: 49.962

4.  Lack of correlation between fibrinolysis and the transformed state of cultured mammalian cells.

Authors:  D M Mott; P H Fabisch; B P Sani; S Sorof
Journal:  Biochem Biophys Res Commun       Date:  1974-11-27       Impact factor: 3.575

5.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

6.  Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm.

Authors:  S Strickland; E Reich; M I Sherman
Journal:  Cell       Date:  1976-10       Impact factor: 41.582

7.  Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study.

Authors:  M B Bernik; H C Kwaan
Journal:  J Clin Invest       Date:  1969-09       Impact factor: 14.808

8.  Studies on the microtubules in heliozoa. IV. The effect of colchicine on the formation and maintenance of the axopodia and the redevelopment of pattern in Actinosphaerium nucleofilum (Barrett).

Authors:  L G Tilney
Journal:  J Cell Sci       Date:  1968-12       Impact factor: 5.285

9.  Secretion of plasminogen activator by stimulated macrophages.

Authors:  J C Unkeless; S Gordon; E Reich
Journal:  J Exp Med       Date:  1974-04-01       Impact factor: 14.307

10.  Production of plasminogen activator by established cell lines of mouse origin.

Authors:  D B Rifkin; R Pollack
Journal:  J Cell Biol       Date:  1977-04       Impact factor: 10.539

View more
  8 in total

1.  Transformation phenotype of polyoma virus-transformed rat fibroblasts: plasminogen activator production is modulated by the growth state of the cells and regulated by the expression of an early viral gene function.

Authors:  B Perbal
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

2.  Modulation of the plasminogen activator activity of a transformed cell line by cell density.

Authors:  H Y Liu; S W Peltz; W F Mangel
Journal:  Mol Cell Biol       Date:  1982-11       Impact factor: 4.272

3.  Plasminogen activator induction and platelet aggregation by phorbol and some of its derivatives: correlation with skin irritancy and tumor-promoting activity.

Authors:  P J Brynes; R Schmidt; E Hecker
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

Review 4.  Extracellular matrix destruction by invasive tumor cells.

Authors:  P A Jones; Y A De Clerck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

5.  Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells.

Authors:  G Grimaldi; P Di Fiore; E K Locatelli; J Falco; F Blasi
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

6.  Correlation between a specific molecular weight form of plasminogen activator and metabolic activity of 3T3 cells.

Authors:  S Jaken; P H Black
Journal:  J Cell Biol       Date:  1981-09       Impact factor: 10.539

7.  Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells.

Authors:  M S Pepper; J D Vassalli; R Montesano; L Orci
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

8.  Regulation of plasminogen activator in 3T3 cells: effect of phorbol myristate acetate on subcellular distribution and molecular weight.

Authors:  S Jaken; P H Black
Journal:  J Cell Biol       Date:  1981-09       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.